Lucid Diagnostics Selects Veeva Vault CDMS for EsoGuard® Study ...Middle East

Vault CDMS to manage clinical data for trial involving Barrett's esophagus and esophageal adenocarcinoma patients PLEASANTON, Calif., May 4, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Lucid Diagnostics Inc. (Nasdaq: LUCD), a commercial-stage, cancer prevention...

Hence then, the article about lucid diagnostics selects veeva vault cdms for esoguard study was published today ( Wednesday 04/05/2022 - 02:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Selects Veeva Vault CDMS for EsoGuard® Study )

Also on site :

• Advanced Coatings and Functional Chemicals Market to Reach USD 485.40 Billion by 2033 Amid Sustainability and High-Performance Demand Strategic Revenue Insights (SRI)
• Supreme Court makes ruling on Boy Scouts sex abuse $2.46 billion settlement
• BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations